{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T11:40:53Z","timestamp":1774266053543,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13048-017-0310-y","type":"journal-article","created":{"date-parts":[[2017,3,11]],"date-time":"2017-03-11T03:39:37Z","timestamp":1489203577000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Does serum CA125 have clinical value for follow-up monitoring of postoperative patients with epithelial ovarian cancer? Results of a 12-year study"],"prefix":"10.1186","volume":"10","author":[{"given":"Na","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhilan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,11]]},"reference":[{"key":"310_CR1","first-page":"887","volume":"309","author":"RC Bast","year":"1983","unstructured":"Bast RC, Klug TL, John E, et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med. 1983;309:887\u201390.","journal-title":"N Engl J Med"},{"key":"310_CR2","first-page":"717","volume":"38","author":"Gynecologic Oncology Branch of the Chinese Medical Association","year":"2003","unstructured":"Gynecologic Oncology Branch of the Chinese Medical Association. The standard diagnosis and treatment of recurrent ovarian cancer (recommended). Chin J Obstet Gynecol. 2003;38:717\u20139.","journal-title":"Chin J Obstet Gynecol"},{"key":"310_CR3","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(10)61268-8","volume":"376","author":"GJ Rustin","year":"2010","unstructured":"Rustin GJ, van der Burg ME, Griffin CL, et al. Early versus delayed treatment of relapsed ovarian cancer (MRC OV05\/EORTC 55955): a randomised trial. Lancet. 2010;376:1155\u201363.","journal-title":"Lancet"},{"key":"310_CR4","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.7150\/jca.16761","volume":"7","author":"J Zeng","year":"2016","unstructured":"Zeng J, Yin J, Song X, et al. Reduction of CA125 Levels During Neoadjuvant Chemotherapy Can Predict Cytoreduction to No Visible Residual Disease in Patients with Advanced Epithelial Ovarian Cancer, Primary Carcinoma of Fallopian tube and Peritoneal Carcinoma. J Cancer. 2016;7:2327\u201332.","journal-title":"J Cancer"},{"key":"310_CR5","first-page":"233","volume":"89","author":"L James","year":"2013","unstructured":"James L, Edward P, John M, et al. Clinical implications of a rising serum CA-125 within the normal range in patients with epithelial ovarian cancer: a preliminary investigation. Gynecol Oncol. 2013;89:233\u20138.","journal-title":"Gynecol Oncol"},{"key":"310_CR6","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1148\/radiol.2353040447","volume":"235","author":"RN Low","year":"2005","unstructured":"Low RN, Duggan B, Barone RM, et al. Treated ovarian cancer: MR imaging, laparotomy reassessment, and serum CA-125 values compared with clinical outcome at 1 year. Radiology. 2005;235:918\u201344.","journal-title":"Radiology"},{"key":"310_CR7","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1007\/s00259-007-0366-9","volume":"34","author":"MJ Garcia-Velloso","year":"2007","unstructured":"Garcia-Velloso MJ, Jurado M, Ceamanos C, et al. Diagnostic accuracy of FDG PET in the follow-up of platinum-sensitive epithelial ovarian carcinoma. Eur J Nucl Med Mol I. 2007;34:1396\u2013405.","journal-title":"Eur J Nucl Med Mol I"},{"key":"310_CR8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/annonc\/mdi012","volume":"16","author":"SM Crawford","year":"2005","unstructured":"Crawford SM, Peace J. Does the nadir CA125 concentration predict a long-term outcome after chemotherapy for carcinoma of the ovary? Ann Oncol. 2005;16:47\u201350.","journal-title":"Ann Oncol"},{"key":"310_CR9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1525-1438.1997.00422.x","volume":"7","author":"T Bese","year":"1997","unstructured":"Bese T, Demirkiran F, Arvas M, et al. What should be the cut-off level of serum CA125 to evaluate the disease status before second-look laparotomy in epithelial ovarian carcinoma? Int J Gynecol Cancer. 1997;7:42\u20135.","journal-title":"Int J Gynecol Cancer"},{"key":"310_CR10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0020-7292(96)02721-X","volume":"54","author":"T Sugiyama","year":"1996","unstructured":"Sugiyama T, Nishida T, Komai K. Comparison of CA 125 assays with abdominopelvic computed tomography and transvaginal ultrasound in monitoring of ovarian cancer. BJOG-Int J Obstet GY. 1996;54:251\u20137.","journal-title":"BJOG-Int J Obstet GY"},{"key":"310_CR11","doi-asserted-by":"publisher","unstructured":"Skates SJ, Greene MH, Buys SS, et al. Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials. Clin Cancer Res. 2017. doi: 10.1158\/1078-0432.CCR-15-2750 .","DOI":"10.1158\/1078-0432.CCR-15-2750"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-017-0310-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T12:27:20Z","timestamp":1498393640000},"score":1,"resource":{"primary":{"URL":"http:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-017-0310-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,11]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["310"],"URL":"https:\/\/doi.org\/10.1186\/s13048-017-0310-y","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,11]]},"article-number":"14"}}